BG Medicine (BGMD) Reports Galectin-3 Might Be Independent Predictor of Adverse Outcomes in ESRD Patients
Go back to BG Medicine (BGMD) Reports Galectin-3 Might Be Independent Predictor of Adverse Outcomes in ESRD Patients| BG Medicine, Inc. (AMEX: BGMD) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $0.68 | |||
| Open | $0.00 | 52 Week Low | $0.10 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-0.66 | |||
| Volume | 99,603 | |||||
